Roche to halt lung cancer treatment trial Ruchika Sharma8 July 2024 5:43 PM ISTBased on these results, patients and investigators will be unblinded and we intend to halt the study.
Submit global regulatory status of Atezolizumab for IV, SC route: CDSCO Panel Tells Roche Products India Dr. Divya Colin12 April 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Roche Products India for granting permission to import and market Atezolizumab...
Delhi police crack down on fake cancer drug racket, seven arrested Ruchika Sharma13 March 2024 4:03 PM ISTNew Delhi: In a groundbreaking operation, the Delhi Police's crime branch has cracked down on a sprawling racket involved in the manufacturing and...
Roche's proposal for marketing Atezolizumab Injection for Subcutaneous route rejected by CDSCO Panel Dr. Divya Colin27 Jan 2024 6:00 PM ISTNew Delhi: Rejecting the drug major Roche's proposal to market the anti-cancer drug Atezolizumab Injection (1875mg/15ml vial) (Tecentriq) for a new...
Roche subcutaneous injection of Tecentriq recommended by EU CHMP for multiple cancer types Ruchika Sharma19 Nov 2023 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
Roche Tecentriq SC approved in Great Britain Ruchika Sharma2 Sept 2023 10:00 AM ISTInjecting Tecentriq subcutaneously (under the skin) takes approximately seven minutes.
Roche reports inadvertent disclosure in lung cancer immunotherapy study Ruchika Sharma23 Aug 2023 2:30 PM ISTBasel: Roche announced today that it has been made aware of an inadvertent disclosure of the second interim analysis of the Phase III SKYSCRAPER-01...
Roche highly anticipated cancer immunotherapy fails in first late-stage trial Ruchika Sharma3 April 2022 9:30 AM ISTTiragolumab works by selectively binding itself to TIGIT, a receptor found on immune system cells that normally serves to prevent an immune attack...
Roche gets USFDA nod to VENTANA PD-L1 Assay as companion test for lung cancer Ruchika Sharma24 Oct 2021 11:00 AM ISTBasel: Roche has recently announced U.S. Food and Drug Administration (USFDA) approval of the VENTANA PD-L1 (SP263) Assay in non- small cell lung...
Roche gets USFDA okay for cancer treatment Tecentriq Ruchika Sharma16 Oct 2021 4:30 PM ISTBasel: Roche has recently announced that the US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) as adjuvant treatment,...
Roche withdraws Tecentriq for treating type of breast cancer in US Ruchika Sharma28 Aug 2021 10:00 AM ISTNew Delhi: Roche Holding AG has decided to withdraw its immunotherapy Tecentriq as a treatment for a type of breast cancer in the United States, the...
Roche Tecentriq Pivotal Phase III data shows hope for cancer patients Ruchika Sharma20 May 2021 11:00 AM ISTBasel: Roche today announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq...
